ncDR

LncRNA	Compound	Cancer	P-value	Effect
ENSG00000261723.1	AKT inhibitor VIII	Breast invasive carcinoma	0.004228952	Sensitive
ENSG00000261723.1	AKT inhibitor VIII	Sarcoma	0.043848921	Sensitive